Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.

Ina Kötter*, Manfred Zierhut, Anja Eckstein, Reinhard Vonthein, Thomas Ness, Ilhan Günaydin, Bodo Grimbacher, Sabine Blaschke, Hans Hartmut Peter, Lothar Kanz, Nicole Stübiger

*Corresponding author for this work
22 Citations (Scopus)
Original languageEnglish
JournalAdvances in Experimental Medicine and Biology
Pages (from-to)521-523
Number of pages3
Publication statusPublished - 2003

Cite this